“Metamizole-Induced Agranulocytosis: Utilisation Trends, Pharmacovigilance Signals and Regulatory Risk-Minimisation in Switzerland”. Swiss Medical Weekly 156, no. 6 (June 26, 2026): 5062. Accessed July 25, 2026. https://smw.ch/index.php/smw/article/view/5062.